Company / Depreciation & Amortization
Edesa Biotech, Inc. Depreciation & Amortization History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$57.6K
FY2021
5-year range
$4.8K / $179.0K
FY2017-FY2021
Trend
+1104.5%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization changed +1104% YoY in FY2021, a notable deviation from the 6-year average annual change of +176%.
Based on SEC 10-K filings.
$57,563 in FY2021 with a 5-year CAGR of -18.3%.
Improved from $179,000 to $57,563 over the past 3 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -31.5%
- 5-Year CAGR
- -18.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.3%, indicating a declining trend.
- In FY2021, depreciation & amortization increased 1104.5% year-over-year.
- Peak depreciation & amortization was recorded in FY2018.
- Lowest depreciation & amortization in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $57.6K | +1104.5% |
| FY2020 | $4.8K | -97.3% |
| FY2018 | $179.0K | +12.2% |
| FY2017 | $159.5K | +0.8% |
| FY2016 | $158.3K | +26.8% |
| FY2015 | $124.8K | +11.3% |
| FY2014 | $112.1K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026